MLchartDataset catalogue

Felcisetrag

Term · Oncology and biomedicine · MLC-T-ONC-013549

A serotonin (5-HT) type 4 receptor agonist with potential gastrointestinal (GI) prokinetic activity. Upon administration, felcisetrag targets and binds to 5-HT4, thereby enhancing its activity. This may enhance GI motility, decrease GI tract and colonic transit time and improve constipation.

Table 1. Record
IdentifierMLC-T-ONC-013549
FieldOncology and biomedicine
Synonyms5-HT4 agonist TAK-954; serotonin agonist TAK-954; serotonin 4 receptor agonist TAK-954
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013549",
  "term": "Felcisetrag",
  "field": "Oncology and biomedicine",
  "definition": "A serotonin (5-HT) type 4 receptor agonist with potential gastrointestinal (GI) prokinetic activity. Upon administration, felcisetrag targets and binds to 5-HT4, thereby enhancing its activity. This may enhance GI motility, decrease GI tract and colonic transit time and improve constipation.",
  "synonyms": [
    "5-HT4 agonist TAK-954",
    "serotonin agonist TAK-954",
    "serotonin 4 receptor agonist TAK-954"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/felcisetrag/"
}

Record 7,197 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.